MarketCap
Facebook
X
TelegramQuarterly report 2024-Q3
added 11-12-2024
Cutera Market Cap 2011-2025 | CUTR
As of December 13, 2025 Cutera has a market cap of $ 1.99 M
Capitalization is the market value of a company whose shares are traded on the stock exchange. It is calculated by multiplying the market price of a share by the total number of the company's shares. Capitalization indicates volatility, risk, and growth potential. This metric is often used for a quick assessment of a company’s investment profile.[1]
Capitalization is an important indicator for investors and analysts, as it helps determine the size and significance of a company in the stock market. Companies with large capitalization are considered more stable and reliable, as they have more resources and financial power to grow and survive in the market.
This metric can be divided into several categories: small (from 300 million to 2 billion dollars), medium (from 2 to 10 billion dollars), and large (over 10 billion dollars). Companies with different levels of capitalization have their own characteristics and risks, so investors usually take this indicator into account when making investment decisions.
Capitalization can also change over time depending on the share price and the number of shares in circulation. Therefore, it is a dynamic indicator that requires constant monitoring and analysis to make well-informed investment decisions.
Annual Market Cap Cutera
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 46.5 M | 442 M | 686 M | 590 M | 409 M | 194 M | 687 M | 243 M | 157 M | 190 M | 139 M | 153 M | 108 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 687 M | 46.5 M | 311 M |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.
Market Cap of other stocks in the Medical devices industry
| Issuer | Market Cap | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Apyx Medical Corporation
APYX
|
45.7 M | $ 3.86 | -3.26 % | $ 134 M |  USA |
 |
BioSig Technologies
BSGM
|
7.3 M | - | 37.08 % | $ 85.7 M | USA |
 |
Abiomed
ABMD
|
16.2 M | - | - | $ 17.2 B | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
933 M | - | - | $ 1.77 B | USA |
 |
Lianluo Smart Limited
LLIT
|
147 M | - | 24.59 % | $ 44.8 M |  China |
 |
Eargo
EAR
|
17 M | - | - | $ 10.2 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
35 M | - | -5.86 % | $ 30.6 M | USA |
 |
Bio-Rad Laboratories
BIO
|
7.81 B | $ 307.92 | -1.93 % | $ 8.69 B | USA |
 |
Apollo Endosurgery
APEN
|
403 M | - | - | $ 475 M | USA |
 |
Acutus Medical
AFIB
|
5.24 M | - | -26.83 % | $ 2.62 M | USA |
 |
Bruker Corporation
BRKR
|
6.9 K | $ 45.13 | -2.67 % | $ 6.72 K | USA |
 |
Allied Healthcare Products
AHPI
|
4.01 M | - | 3.58 % | $ 2.21 M | USA |
 |
Conformis
CFMS
|
12.6 M | - | - | $ 16.4 M | USA |
 |
Abbott Laboratories
ABT
|
235 B | $ 125.1 | 1.48 % | $ 218 B | USA |
 |
Boston Scientific Corporation
BSX
|
155 B | $ 92.34 | 0.64 % | $ 136 B | USA |
 |
CryoLife, Inc.
CRY
|
906 M | - | -4.14 % | $ 702 M | USA |
 |
EDAP TMS S.A.
EDAP
|
60 M | $ 2.56 | 8.94 % | $ 95.5 M |  France |
 |
Invacare Corporation
IVC
|
24.1 M | - | - | $ 24.7 M | USA |
 |
Cardiovascular Systems
CSII
|
588 M | - | 0.15 % | $ 844 M | USA |
 |
IRIDEX Corporation
IRIX
|
48.1 M | $ 0.92 | -4.72 % | $ 14.8 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
1.05 M | - | 1.15 % | $ 34.5 M | USA |
 |
IRadimed Corporation
IRMD
|
670 M | $ 96.35 | -1.06 % | $ 1.22 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
589 M | $ 17.7 | -3.46 % | $ 408 M | USA |
 |
Soliton, Inc.
SOLY
|
229 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
7.99 M | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
339 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
185 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
677 M | - | - | $ 111 M |  Canada |
 |
LivaNova PLC
LIVN
|
2.28 B | $ 62.79 | -1.82 % | $ 3.41 B |  Britain |
 |
Pulmonx Corporation
LUNG
|
341 M | $ 2.53 | 0.86 % | $ 99 M | USA |
 |
Dynatronics Corporation
DYNT
|
1.95 M | - | 14.99 % | $ 929 K | USA |
 |
Intersect ENT, Inc.
XENT
|
735 M | - | - | $ 955 M | USA |
 |
InMode Ltd.
INMD
|
1.43 B | $ 14.56 | 0.76 % | $ 1.15 B | Israel |
 |
Cognyte Software Ltd.
CGNT
|
661 M | $ 9.88 | 0.05 % | $ 709 M | Israel |
 |
Myomo
MYO
|
5.64 M | $ 1.06 | -1.85 % | $ 7.47 M | USA |
 |
Second Sight Medical Products
EYES
|
225 K | - | -0.97 % | $ 54.4 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
1.88 B | $ 13.41 | -4.56 % | $ 1.03 B | USA |
 |
NuVasive
NUVA
|
2.29 B | - | - | $ 2.07 B | USA |
 |
Align Technology
ALGN
|
13.9 B | $ 165.15 | 0.78 % | $ 12.4 B | USA |
 |
Accuray Incorporated
ARAY
|
160 M | $ 1.07 | -3.18 % | $ 110 M | USA |
 |
Avinger
AVGR
|
2.59 M | - | -20.74 % | $ 369 K | USA |
 |
ClearPoint Neuro
CLPT
|
466 M | $ 12.81 | -1.23 % | $ 346 M | USA |
 |
Orthofix Medical
OFIX
|
669 M | $ 15.51 | -1.27 % | $ 591 M |  Curacao |
 |
FONAR Corporation
FONR
|
85.2 M | $ 14.86 | -0.03 % | $ 97.4 M | USA |
 |
AxoGen
AXGN
|
859 M | $ 30.33 | 1.15 % | $ 1.34 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
2.82 B | - | - | $ 3.31 B | USA |
 |
GBS
GBS
|
2.48 M | - | -0.57 % | $ 7.12 M | USA |
 |
CONMED Corporation
CNMD
|
1.94 B | $ 40.78 | 2.33 % | $ 1.26 B | USA |
|
LENSAR
LNSR
|
130 M | $ 11.48 | -0.17 % | $ 132 M | USA |